Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and ...

These companies could innovate their way to success.

One popular biotech ETF was up about 1% after the Federal Reserve announced its third interest-rate cut for the year. The Federal Reserve cut interest rates as expected - but for the biotech sector, ...

The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently ...

The S&P 500 Healthcare sector (XLV) experienced a rise in average short interest during November, moving from 1.97% to 2.12%.

Applied’s lead candidate is a selective aldose reductase inhibitor called govorestat, an asset that failed to hit primary endpoints in late-stage trials for a progressive neuromuscular disease called ...

Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...

Indivumed, of Hamburg, Germany, is no stranger to cancer-centered collaborations; in August 2021, the company announced a ...